4//SEC Filing
Shah Sujal 4
Accession 0001062993-24-006513
CIK 0001042074other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:03 PM ET
Size
34.8 KB
Accession
0001062993-24-006513
Insider Transaction Report
Form 4
Shah Sujal
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−14,372→ 0 totalExercise: $8.43Exp: 2029-01-28→ Common Stock (14,372 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−2,288→ 12,845 totalExercise: $5.78Exp: 2031-01-25→ Common Stock (2,288 underlying) - Exercise/Conversion
Common Stock
2024-03-13$10.00/sh+11,649$116,490→ 279,200 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−52,084→ 0 totalExercise: $1.72Exp: 2027-01-18→ Common Stock (52,084 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−18,899→ 0 totalExercise: $9.21Exp: 2027-10-26→ Common Stock (18,899 underlying) - Exercise/Conversion
Common Stock
2024-03-13$9.21/sh+18,899$174,060→ 364,808 total - Exercise/Conversion
Common Stock
2024-03-13$8.43/sh+14,372$121,156→ 382,305 total - Exercise/Conversion
Common Stock
2024-03-13$1.06/sh+14,625$15,503→ 293,825 total - Exercise/Conversion
Common Stock
2024-03-13$1.72/sh+52,084$89,584→ 345,909 total - Exercise/Conversion
Common Stock
2024-03-13$11.69/sh+3,125$36,531→ 367,933 total - Exercise/Conversion
Common Stock
2024-03-13$4.05/sh+22,076$89,408→ 404,381 total - Exercise/Conversion
Common Stock
2024-03-13$2.94/sh+1$3→ 406,670 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−3,125→ 0 totalExercise: $11.69Exp: 2028-01-23→ Common Stock (3,125 underlying) - Exercise/Conversion
Common Stock
2024-03-13$5.78/sh+2,288$13,225→ 406,669 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−11,649→ 0 totalExercise: $10.00Exp: 2025-01-06→ Common Stock (11,649 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−14,625→ 0 totalExercise: $1.06Exp: 2026-01-25→ Common Stock (14,625 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−22,076→ 0 totalExercise: $4.05Exp: 2030-05-14→ Common Stock (22,076 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−1→ 35,799 totalExercise: $2.94Exp: 2032-01-24→ Common Stock (1 underlying)
Footnotes (7)
- [F1]The option vests as to 1/4 of the underlying shares on the first anniversary of the grant date, and vests as to 1/48 of the underlying shares monthly thereafter.
- [F2]The option vests as to 1/48 of the underlying shares monthly from October 27, 2017.
- [F3]The option vests as to 1/4 of the underlying shares on January 1, 2019, and vests as to 1/48 of the underlying shares monthly thereafter.
- [F4]The option vests as to 1/4 of the underlying shares on January 1, 2020, and vests as to 1/48 of the underlying shares monthly thereafter.
- [F5]The option vests as to 1/48 of the underlying shares monthly from January 31, 2020.
- [F6]The option vests as to 1/48 of the underlying shares monthly from January 1, 2021.
- [F7]The option vests as to 1/48 of the underlying shares monthly from January 1, 2022.
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001588861
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:03 PM ET
- Size
- 34.8 KB